» Articles » PMID: 39846533

Epigenetic Mechanisms of Endocrine-Disrupting Chemicals in Breast Cancer and Their Impact on Dietary Intake

Overview
Journal J Xenobiot
Date 2025 Jan 23
PMID 39846533
Authors
Affiliations
Soon will be listed here.
Abstract

Addressing the consequences of exposure to endocrine-disrupting chemicals (EDCs) demands thorough research and elucidation of the mechanism by which EDCs negatively impact women and lead to breast cancer (BC). Endocrine disruptors can affect major pathways through various means, including histone modifications, the erroneous expression of microRNA (miRNA), DNA methylation, and epigenetic modifications. However, it is still uncertain if the epigenetic modifications triggered by EDCs can help predict negative outcomes. Consequently, it is important to understand how different endocrine disrupters or signals interact with epigenetic modifications and regulate signalling mechanisms. This study proposes that the epigenome may be negatively impacted by several EDCs, such as cadmium, arsenic, lead, bisphenol A, phthalates, polychlorinated biphenyls and parabens, organochlorine, and dioxins. Further, this study also examines the impact of EDCs on lifestyle variables. In breast cancer research, it is essential to consider the potential impacts of EDC exposure and comprehend how EDCs function in tissues.

References
1.
Aldeli N, Murphy D, Hanano A . Impact of dioxins on reproductive health in female mammals. Front Toxicol. 2024; 6:1392257. PMC: 11106427. DOI: 10.3389/ftox.2024.1392257. View

2.
Van Maele-Fabry G, Lombaert N, Lison D . Dietary exposure to cadmium and risk of breast cancer in postmenopausal women: A systematic review and meta-analysis. Environ Int. 2015; 86:1-13. DOI: 10.1016/j.envint.2015.10.003. View

3.
Mielke H, Gonzales C, Powell E, Egendorf S . Lead in Air, Soil, and Blood: Pb Poisoning in a Changing World. Int J Environ Res Public Health. 2022; 19(15). PMC: 9368099. DOI: 10.3390/ijerph19159500. View

4.
Sanders T, Liu Y, Buchner V, Tchounwou P . Neurotoxic effects and biomarkers of lead exposure: a review. Rev Environ Health. 2009; 24(1):15-45. PMC: 2858639. DOI: 10.1515/reveh.2009.24.1.15. View

5.
Sage A, Minatel B, Ng K, Stewart G, Dummer T, Lam W . Oncogenomic disruptions in arsenic-induced carcinogenesis. Oncotarget. 2017; 8(15):25736-25755. PMC: 5421966. DOI: 10.18632/oncotarget.15106. View